Skip to main content

Advancing Microfluidic Screening for Metabolic Engineering and Antibody Discovery

case study icon

Advancing Microfluidic Screening for Metabolic Engineering and Antibody Discovery

case study icon
SLAS 2024 Microscale Innovation in Life Sciences Symposium

Summary: Harnessing Microfluidics and Biosensors for Efficient Molecule Production

This 2021 study, published in Proceedings of the National Academy of Sciences, demonstrates how the Pico-Mine® platform is transforming high-throughput screening. Through a biosensor-in-microdroplet approach, researchers successfully streamlined molecule production across multiple cell libraries. This microfluidic-assisted workflow, compatible with various biosensors, reveals enhanced potential for discovering novel antibody and metabolic engineering targets.

Research highlights

  • Study Title: Sorting for Secreted Molecule Production Using a Biosensor-In-Microdroplet Approach
  • Authors: Emily K. Bowman, James M. Wagner, Shuo-Fu Yuan, Matthew Deaner, Claire M. Palmer, Simon D’Oelsnitz, Lauren Cordova, Xin Li, Frank F. Craig, Hal S. Alper
  • Published In: Proceedings of the National Academy of Sciences, 2021
  • DOI: 10.1073/pnas.2106818118

Key findings

  • Scalable Screening Methodology: This study used Pico-Mine®’s high-throughput droplet-based system to screen secretor cell libraries across various microbes, accelerating the discovery of productive targets in metabolic engineering.
  • Cell and Library Agnostic Workflow: By coencapsulating cells with biosensors or using pico-injection, researchers optimized workflows across different cell types, from E. coli to Yarrowia lipolytica.
  • Broad Utility in Antibody Discovery: The biosensor-based microdroplet approach offers a versatile screening option for antibody discovery and other high-value targets.

Additional Highlights

  • Enhanced Throughput: Up to two million droplets, each encapsulating individual cells, were screened using Pico-Mine®, providing high-resolution data on molecule secretion.
  • Flexible Applications: This method is adaptable for both industrial and research applications, including drug discovery, enzyme engineering, and metabolic optimization.

The Next Generation: Cyto-Mine® Chroma

Automate. Accelerate. Analyze millions of cells in a single day.

Think Cyto-Mine®, but supercharged, enabling multiplexing and greater assay flexibility to fit your needs. It means that you can examine vastly greater numbers of cells — and isolate the most valuable ones— with unparalleled precision.

Cyto-Mine® Chroma
Contact sales